BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bellomo G. Asymptomatic hyperuricemia following renal transplantation. World J Nephrol 2015; 4(3): 324-329 [PMID: 26167455 DOI: 10.5527/wjn.v4.i3.324]
URL: https://www.wjgnet.com/2220-6124/full/v4/i3/324.htm
Number Citing Articles
1
Adla B. Hassan, Kanz W. Ghalib, Haitham A. Jahrami, Amgad E. El-Agroudy. Prevalence of Musculoskeletal Manifestations in Adult Kidney Transplant’s Recipients: A Systematic ReviewMedicina 2021; 57(6): 525 doi: 10.3390/medicina57060525
2
Brian Duty, Michael Lam. Smith's Textbook of Endourology2019; : 827 doi: 10.1002/9781119245193.ch69
3
Yanchun Li, Min Liu, Xuelei Zhang, Yuewu Lu, Juan Meng. Switching from allopurinol to febuxostat: efficacy and safety in the treatment of hyperuricemia in renal transplant recipientsRenal Failure 2019; 41(1): 595 doi: 10.1080/0886022X.2019.1632717
4
Abbasi Muhammad Tanzeel, Asghar Muhammad Rashid, Bashir Khuram, Hashmi Muhammad Nauman. Hyperuricemia in Renal patients: Treat or not to treatArchives of Clinical Nephrology 2021; : 050 doi: 10.17352/acn.000056
5
João Pedro Floriano, Paula C. Nahas, Flávia M. S. de Branco, Aline S. dos Reis, Luana T. Rossato, Heitor O. Santos, Larissa S. Limirio, Sebastião R. Ferreira-Filho, Erick P. de Oliveira. Serum Uric Acid Is Positively Associated with Muscle Mass and Strength, but Not with Functional Capacity, in Kidney Transplant PatientsNutrients 2020; 12(8): 2390 doi: 10.3390/nu12082390
6
Larissa S. Limirio, Heitor O. Santos, Aline S. dos Reis, Erick P. de Oliveira. Association Between Dietary Intake and Serum Uric Acid Levels in Kidney Transplant PatientsJournal of Renal Nutrition 2021; 31(6): 637 doi: 10.1053/j.jrn.2020.11.009
7
Api Chewcharat, Yuan‐Ting Chang, Charat Thongprayoon, Anthony Crisafio, Tarun Bathini, Michael A. Mao, Wisit Cheungpasitporn. Efficacy and safety of febuxostat for treatment of asymptomatic hyperuricemia among kidney transplant patients: A meta‐analysis of observational studiesClinical Transplantation 2020; 34(4) doi: 10.1111/ctr.13820
8
Xiaoyu Zi, Xi Zhang, Chuan Hao, Zhenxing Wang. Risk factors and management of hyperuricemia after renal transplantationFrontiers in Surgery 2023; 9 doi: 10.3389/fsurg.2022.956213
9
Marta Ferreira, Carlos Jiménez, María Ovidia Lopez, Elena González, María José Santana, Rafael Selgas. Short-term efficacy and safety of treatment with febuxostat in kidney transplant recipient. An unicentric observational studyNefrología (English Edition) 2018; 38(3): 331 doi: 10.1016/j.nefroe.2017.03.010
10
Inese Folkmane, Lilian Tzivian, Elizabete Folkmane, Elina Valdmane, Viktorija Kuzema, Aivars Petersons. Predictors of Hyperuricemia after Kidney Transplantation: Association with Graft FunctionMedicina 2020; 56(3): 95 doi: 10.3390/medicina56030095
11
Marta Ferreira, Carlos Jiménez, María O. Lopez, Elena González, María José Santana, Rafael Selgas. Eficacia y seguridad a corto plazo del tratamiento con febuxostat en el paciente trasplantado renal. Estudio observacional unicéntricoNefrología 2018; 38(3): 331 doi: 10.1016/j.nefro.2017.03.020
12
Fransiska Romana Simbolon, Su‐Shin Lee, Yi‐Chun Tsai, Wen‐Chan Tsai, Gau‐Tyan Lin, Yi‐Ching Tung, Hung‐Pin Tu. Risk of incident gout in kidney transplant recipients: A retrospective cohort studyInternational Journal of Rheumatic Diseases 2018; 21(11): 1993 doi: 10.1111/1756-185X.13393